Table 1.
Patterns of Use of Anti-Hypertensive Drugs Among Patients with Single-Versus Multidrug Hypertension
| Drug class, N (%) | Overall N=9,975 (100.0%) | No Drugs n=1,909 (19.1%) | 1 Drug n=2,363 (23.7%) | 2 Drugs n=2,390 (24.0%) | 3 Drugs n=1,796 (18.0%) | 4 or More Drugs n=1,517 (15.2%) |
|---|---|---|---|---|---|---|
| ACE inhibitors or angiotensin II Inhibitors | 6,167 (62.2) | – | 1,406 (59.5) | 1,817 (76.0) | 1,538 (85.6) | 1,406 (92.7) |
| Thiazide or loop diuretics | 3,805 (38.1) | – | 221 (9.4) | 953 (39.9) | 1,265 (70.4) | 1,366 (90.0) |
| β-blockers | 2,846 (28.5) | – | 271 (11.5) | 691 (28.9) | 815 (45.4) | 1,069 (70.5) |
| Calcium channel blockers | 3,518 (35.3) | – | 265 (11.2) | 857 (35.9) | 1,080 (60.1) | 1,316 (86.8) |
| Other antihypertensives | 958 (9.6) | – | 41 (1.7) | 88 (3.7) | 212 (11.8) | 617 (40.7) |
| α-blockers | 1,512 (15.2) | – | 156 (6.6) | 351 (14.7) | 389 (21.7) | 616 (40.6) |
Note: Percentages of individual drug classes are given within columns: overall, and by number of drugs in regimen.
ACE, angiotensin-converting enzyme.